Aurinia Pharmaceuticals Incis A Biopharmaceutical Company Based In Victoriabritish Columbiacanadait Focuses On Developing Therapies For Autoimmune Diseases That Have Significant Unmet Medical Needsthe Company Operates Globallywith A Commercial Hub In Rockvillemaryland Aurinia S Key Product Is Lupkynisvoclosporin An Fda Approved Oral Immunosuppressant For Treating Active Lupus Nephritis In Adultsthe Company Is Also Exploring Voclosporin For Other Conditionsincluding Psoriasis And Kidney Transplantationadditionallyaurinia Is Developing Aur200 And Aur300Which Target Autoimmune And Fibrotic Diseasesthe Company Collaborates With Otsuka Pharmaceutical Co Ltd For The Development And Commercialization Of Voclosporinemphasizing Its Commitment To Improving Patient Outcomes In The Field Of Autoimmune Diseases
